Skip to content

Homoeopathic treatment of irregular menses

Repertorial approach of treating menstrual irregularities with individualized homoeopathic medicines in early reproductive age group: A Double-blind, randomized, placebo-controlled efficacy trial

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/04/041659
Enrollment
92
Registered
2022-04-05
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N926- Irregular menstruation, unspecified

Interventions

Intervention1: Indicated homoeopathic medicines in centesimal potencies: Intervention is planned as administering indicated homoeopathic medicines in centesimal potencies. Each dose will consist of 4
dosage and repetition depending upon the individual requirement of the cases. Patients will be advised to refrain from handling the globules or from eating, drinking, smoking or brushing teeth within
dosage and repetition depending upon the individual requirement of the cases. Duration of therapy: 4 months. Both medicines and placebos will be re-packed in identical glass bottles and labelled with

Sponsors

D N De Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients suffering from menstrual irregularities (ICD 10: N92.6) 2. Differential diagnosis established by USG and other laboratory investigations as appropriate. 3. Age: 11-25 years. 4. Patients taking oral contraceptive pills will be considered for the study after giving a wash-out period of 1 month. 5. Literate patients, who can read and write in Bengali, and/or English. 6. Patients giving written informed consent to participate in the study

Exclusion criteria

Exclusion criteria: 1. Patients suffering from carcinoma of cervix, chronic tubo-ovarian mass, endometrial carcinoma, genital tuberculosis. 2. Vulnerable population â?? unconscious, ambulatory, too sick for consultation, differently abled, terminally or critically ill patients, mentally incompetent people. 3. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life- threatening illness affecting quality of life or any organ failure. 4. Blood haemoglobin level less than 7g/dl. 5. Participants with habits of tobacco chewing and/or smoking, alcoholism and/or any other form(s) of substance abuse and/or dependence. 6. Self-reported immune-compromised state. 7. Undergoing homeopathic treatment for any chronic disease within last 6 months.

Design outcomes

Primary

MeasureTime frame
The proportion of participants between groups in whom menstrual irregularities can be correctedTimepoint: Baseline, after each menstrual cycle, up to 4 cycles

Secondary

MeasureTime frame
Menstrual Distress Questionnaire (MDQ) scoreTimepoint: Baseline, and after each menstrual cycle, up to 4 cycles

Countries

India

Contacts

Public ContactProf Dr Rajat Kumar Pal

D N De Homoeopathic Medical College and Hospital

drrajatkumarpal@gmail.com9433130996

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 5, 2026